1-3 of 3
Lina Reslan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

LFB-R603, a Third-Generation Monoclonal Anti-CD20 Antibody Displays An Additive Antitumor Activity with Antileukemic Chemotherapeutic Agents in Mouse Xenograft Models

Isabel Tourais Esteves, Ph. D., Charles Dumontet, M. D., Ph. D., Stéphanie Herveau, Lina Reslan, Ph. D., Frédérique Brune, Pharm. D., Laurence Van Overtvelt, Ph. D., Margarita Salcedo, PhD, Bénédicte Fournès, Ph. D.
Journal: Blood
Blood (2011) 118 (21): 1660.
https://doi.org/10.1182/blood.V118.21.1660.1660
Published: 2011
Journal Articles

Comparison of Cytotoxic Mechanisms of Anti-CD20 Antibodies GA101 and Rituximab Against Fresh Chronic Lymphocytic Leukemia Cells

Lina Reslan, PhD, Stéphane Dalle, Cindy Tournebize, AE, Stephanie Herveau, Emeline Cros, AE, Charles Dumontet
Journal: Blood
Blood (2010) 116 (21): 2467.
https://doi.org/10.1182/blood.V116.21.2467.2467
Published: 2010
Journal Articles

Compared Antitumor Activity of GA101 and Rituximab against the Human RL Follicular Lymphoma Xenografts in SCID Beige Mice.

Stéphane Dalle, Lina Reslan, Stéphanie Brunet Manquat, Franck Herting, Christian Klein, Pablo Umana, Charles Dumontet
Journal: Blood
Blood (2008) 112 (11): 1585.
https://doi.org/10.1182/blood.V112.11.1585.1585
Published: 2008